<DOC>
	<DOCNO>NCT01347619</DOCNO>
	<brief_summary>The investigator propose evaluate effectiveness 3 different method promote dissemination adoption evidenced-based review guide nursing home setting . Specifically , investigator adapt Comparative Effectiveness Research ( CER ) Review product develop Agency Healthcare Research Quality ( AHRQ ) , specifically related off-label use atypical antipsychotic drug , improve penetration practice nursing home ( NH ) setting . The investigator propose follow specific aim : AIM 1 : NEEDS ASSESSMENT To conduct needs assessment NH setting relevant AHRQ Comparative Effectiveness Research Summary Guide ( CERSG ) entitle `` Off-Label Use Atypical Antipsychotic Drugs . '' The assessment identify : ( ) interest barrier use AHRQ atypical antipsychotic CERSG NH setting ; ( b ) key audience stakeholder influence atypical antipsychotic drug use NHs ; ( c ) approach integrate comparative effectiveness research product NH setting . AIM 2 : PRODUCTION OF THE TOOLKIT Guided need assessment , investigator produce toolkit contain tailor CERSG-based product target key audience stakeholder NH setting . The target audience ( ) final CERSG-based product identify Aim 1 , potentially include : ( ) facility leadership [ NH administrator , Medical Director , Director Nursing ] ; ( b ) prescribers consultant pharmacist ; ( c ) nursing staff [ register nurse , license practical nurse , certify nurse assistant ] . AIM 3 : EVALUATING THE EFFECTIVENESS OF THE TOOLKIT To evaluate effectiveness toolkit three dissemination strategy use match , cluster randomize trial . NHs first arm receive toolkit web access material ; NHs second arm receive toolkit , web access , periodic audit feedback report antipsychotic prescribe NH leadership , fax educational message adapt AHRQ atypical antipsychotic CERSG prescribers ; NHs third arm receive previous item plus face-to-face academic detailing . Primary outcomes evaluation RE-AIM evaluation domain ( reach , efficacy , adoption , implementation , maintenance ) .The investigator also include assessment facility-level change use atypical antipsychotic drug .</brief_summary>
	<brief_title>iADAPT : Off Label Use Antipsychotics Nursing Home</brief_title>
	<detailed_description />
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Qualidigmaffiliated Nursing Home facility Connecticut agree participate . Participants study include resident employee participate nursing home resident within nurse home . All member study population 18 year old . Does meet inclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Comparative Effectiveness Research Summary Guide ( CERSG )</keyword>
	<keyword>anti-psychotic use</keyword>
	<keyword>Nursing Home</keyword>
	<keyword>Long-term care</keyword>
	<keyword>Qualitative assessment influence CERSG adoption NH</keyword>
	<keyword>Development toolkit CERSG-based product NHs</keyword>
	<keyword>Evaluation 3 implementation strategy toolkit</keyword>
</DOC>